In eukaryotes, glycans differ from proteins in that their biosynthesis derives from a series of enzymatic reactions in the endoplasmic reticulum and Golgi apparatus and not from a template-driven process. Glycans, depending on class, may be branched, and their structural characterization requires determination of stereochemistry. The function of a glycan depends on the protein to which it binds. Thus, a difference in a single monosaccharide linkage in a glycan alters the partners to which a glycan, and its attached protein, binds.
Proteins exist as populations of proteoforms. For glycoproteins, the large number of proteoforms reflects glycan heterogeneity at each glycosylation site. Thus, the population of glycoprotein proteoforms present differs in their capacities to bind to partners that contain carbohydrate-binding domains.
In the late 1980s, Cathy was among the first to recognize the utility of tandem mass spectrometry for characterization of glycoconjugates. Today, her 1988 publication defining the dissociation nomenclature for glycans has been cited more than 2200 times, including 108 in 2017. Cathy delineated the strategy of producing the greatest degree of structural detail on glycans in a single tandem mass spectrometry step. This innovation was critical because the effectiveness with which we can solve biological problems depends on the ability to sequence glycans in high throughput. The challenge is to produce a sufficient number of glycosidic and cross-ring cleavage product ions for glycan sequencing in a single tandem MS step.
Cathy recognized that while collisional dissociation provides useful information, its utility is limited by low abundances of key cross-ring cleavage product ions. She developed activated electron dissociation methods for glycans and glycoconjugates that are inherently more effective for producing cross-ring cleavages. To do this, she investigated the metal cationic precursor ion forms that produce the most informative product ion patterns. She applied these to electron capture, electron detachment, and electron transfer dissociation methods for glycans and glycoconjugates. She demonstrated these methods on a time scale compatible with online LC-tandem MS. She has recently developed an approach for using ion mobility profiles for identification of glycans and glycopeptides. These methods are the future of glycan and glycoconjugate analysis.
Cathy was the first to demonstrate top-down tandem MS on an intact glycoprotein. This is significant because most cell surface and secreted proteins are glycosylated, and progress in Celebrating with many friends and colleagues biomedicine depends on the ability to characterize glycosylated proteoforms. Each glycosylation site on a glycoprotein reflects a distribution of glycoforms, multiplying the number of molecular forms (proteoforms) of the protein, and represents a gradation of biological function based on the differing abilities to interact with carbohydrate binding proteins.
All scientists working in biomedical glycosciences are in debt to Cathy's contributions on understanding the fundamental dissociation mechanisms and application of advanced activated dissociation methods. The future leaders of biomedicine will be those capable of understanding the functions of mature protein molecules, necessarily including glycosylation.
In addition to her seminal work in glycobiology, Cathy has made an indelible impact on the field of mass spectrometry through her incomparable service, her wide-ranging collaborations, and her generous support of colleagues, both young and old. Cathy's patience, wisdom, and vision have guided and inspired a generation of students, postdocs, and faculty at Boston University. The great esteem and affection of the scientific community for Cathy is evidenced by the enthusiastic response to this Special Focus in her honor, both by excellent manuscripts from many colleagues and by prompt, insightful comments from many reviewers. This issue contains twentyone contributions, beginning with an Account and Perspective, 
